当前位置:首页 - 行情中心 - 泽璟制药-U(688266) - 财务分析

泽璟制药-U

(688266)

  

流通市值:145.85亿  总市值:145.85亿
流通股本:2.65亿   总股本:2.65亿

泽璟制药-U(688266)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.45亿元,每股收益-0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益160071.20万元,未分配利润-201841.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产310474.80万元,负债150403.60万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入108,244,408.58386,438,784.02282,104,804.49219,928,154.33
营业总成本158,939,244.62778,740,484.69541,758,673.77358,131,612.47
营业利润-45,624,274.29-297,782,398.33-216,367,630.78-122,160,868.74
利润总额-45,623,831.81-299,084,511.68-217,267,650.25-122,742,352.09
净利润-44,630,785.9-295,134,953.99-214,296,136.14-120,802,756.89
其他综合收益104,914.23-2,670,887.432,096,126.562,588,560.46
综合收益总额-44,525,871.67-297,805,841.42-212,200,009.58-118,214,196.43
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,722,994,152.52,520,336,094.42,499,759,209.722,510,460,495.25
非流动资产合计381,753,800.44366,870,730.91359,302,691.37360,500,589.55
资产总计3,104,747,952.942,887,206,825.312,859,061,901.092,870,961,084.8
流动负债合计1,208,189,825.591,135,181,236.871,050,897,165.5948,192,490.01
非流动负债合计295,846,130.38107,188,540.0758,730,498.482,186,675.73
负债合计1,504,035,955.971,242,369,776.941,109,627,663.91,030,379,165.74
归属于母公司股东权益合计1,593,693,581.821,632,852,717.681,732,140,193.421,817,617,173.95
股东权益合计1,600,711,996.971,644,837,048.371,749,434,237.191,840,581,919.06
负债和股东权益合计3,104,747,952.942,887,206,825.312,859,061,901.092,870,961,084.8
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计310,024,749.02611,870,449.9397,786,732.2300,201,241.2
经营活动现金流出小计221,000,881.05844,621,099.47627,006,195.64433,917,350.64
经营活动产生的现金流量净额89,023,867.97-232,750,649.57-229,219,463.44-133,716,109.44
投资活动现金流入小计117,324,826.941,262,440,127.61660,367,287.88307,191,397.47
投资活动现金流出小计433,226,291.731,197,601,229.98742,818,129.69731,108,044.42
投资活动产生的现金流量净额-315,901,464.7964,838,897.63-82,450,841.81-423,916,646.95
筹资活动现金流入小计349,000,0002,176,172,835.721,937,272,835.721,599,649,923.22
筹资活动现金流出小计254,387,860.3666,807,032.68457,552,418.43212,385,477.61
筹资活动产生的现金流量净额94,612,139.71,509,365,803.041,479,720,417.291,387,264,445.61
汇率变动对现金及现金等价物的影响10,798.48216,718.78312,127.21414,893.65
现金及现金等价物净增加额-132,254,658.641,341,670,769.881,168,362,239.25830,046,582.87
期末现金及现金等价物余额1,945,522,532.842,077,777,191.481,904,468,660.851,566,153,004.47
最新报告期:2024-04-24
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
广发证券李安飞,罗佳荣-0.550.591.142024-04-24
西部证券李梦园-0.940.161.432024-04-23
西南证券杜向阳,汤泰萌0.001.093.092024-04-23
浙商证券孙建,郭双喜-0.690.051.482024-04-20
中信证券陈竹,韩世通-0.43-0.04--2024-02-26
TOP↑